Event Calendar
Prev MonthPrev Month Next MonthNext Month
RXPP 6220: Treatment of Anxiety Disorders Treatment of Sleep Disorders | via NMSU
Saturday, November 30, 2024, 9:00 AM to Sunday, December 01, 2024, 6:00 PM CDT
Category: Events

RXPP 6220: Treatment of Anxiety Disorders Treatment of Sleep Disorders | via NMSU
(13.5 Hours)
ONLINE

The Iowa Psychological Association is pleased to partner with New Mexico State University's Clinical Psychopharmacology Post- Doctoral Masters Degree Program to offer Continuing Education (CE) training to IPA members.

Topic:
RXPP 6220: Treatment of Anxiety Disorders Treatment of Sleep Disorders

Credit Hours: 13.5 CEUs (Provided by NMSU, Sponsored by APA) NMSU is approved by the American Psychological Association to sponsor continuing education for psychologists. NMSU maintains responsibility for the program and its content

Location: Online

Date/Time
November 30 & December 1, 2024
9:00am - 6:00pm CST

Instructor:
Erin Conway, PsyD, BCB, BCN, MSCP

Cost
$300: IPA Member
$200: IPA Lifetime Member
$200: IPA ECP Member
$130: IPA Retired Member
$0: IPA Student Member
$450: Non-Member

About This Workshop

In this HYBRID RXPP 604 and 605 class we continue our study of clinical psychopharmacology through the study of anxiety disorders and disturbances in sleep from a Psycho biosocial Model of care. Significant emphasis will be placed on the psychopharmacology for the treatment of anxiety disorders. Diagnosis and treatment of broad spectrum anxiety disorders (including general anxiety, OCD) will be discussed. Particular anxiety disorders of children will also be discussed. In Day 2 disturbances in sleep, treatment, and sleep hygiene will be covered

Learning Objectives

Participants will be able to:
Day One Objectives:
1. List three mechanisms of action of psychopharmacological interventions used in the treatment of anxiety disorders.
2. List and then match at least three anxiolytic drugs; as indicated for specific anxiety disorders, on the spectrum of anxiety disorders.
3. List three, FDA approved, pharmacological interventions for Generalized Anxiety Disorder.
4. List two, FDA approved, pharmacological interventions for Post-Traumatic Stress Disorder.
5. List two psychological interventions that should be used first for phobic behavior(s) BEFORE implementing a psychotropic agent.
6. List and match two medications to be augmented with combined (modality) pharmacotherapy.
7. List what type of an anxiety disorder(s) would Beta Blockers be indicated.
8. List three components of Hypothalamus-Pituitary -Adrenal Axis; and the difference between adaptive and maladaptive feedback loops.
9. List three (Central Nervous System) subcortical correlates associated with anxiety disorders.
10. List three neuroimaging techniques/studies used to identity cell bodies synthesis and pathways associated with anxiety disorders.
11. List the presynaptic and postsynaptic (neurotransmission) activity involved in the specific primary neuroreceptors involved in excitatory vs. inhibitory/relaxation actions central to anxiety disorders.
12. For the following three drug classes (Serotonergic, Gabaminergic, Beta Blockers), the student will list two benefits and risks associated with their use.
13. List three signs/symptoms that an individual has develop tolerance on anti-anxiety medication.
14. List three signs/symptoms that an individual has develop withdrawal on anti-anxiety medication.
15. List two Empirically Based Treatments in the management of children/adolescents with anxiety disorders.
16. List three contraindications of the use of anxiolytics in the treatment of children/adolescents.
17. List three contraindications of the use of anxiolytics in the treatment of child bearing (age) women and elderly populations.

Day Two Objectives:
1. List three mechanisms of action of hypnotic medication and common sleep aids.
2. List two short and two long acting hypnotic agents/sleep aids; and able to select the most appropriate hypnotic for different types of sleep disorders (such as early morning awakening versus phase disorders).
3. List two issues related to the development of dependence, means of avoiding dependence, and a means of minimizing dependence with the use of hypnotic medications.
4. List one neuroimaging technique and one neurological study used to identity activity and stimulations (or lack thereof) associated with disturbances in sleep and the sleep wake cycle.
5. Diagram the sleep wake cycle specific to the use of hypnotic agents.
6. List the three etiologies of sleep disorders.
7. List three general medical conditions that produce/manifest into comorbid sleep disorders.
8. List three psychiatric syndromes that produce/manifest into comorbid sleep disorders.
9. In a written paragraph, explain how the psychobiosocial model is applicable in the treatment of sleep disorders, (from acute care to long term; including best practices in sleep hygiene.)
10. Rank order sleep hygiene, psychological interventions, and hypnotics; as the first to last tier interventions in the treatment of disturbances of sleep.
11. List five practical applications of sleep hygiene.
12. List three contraindications of the use of hypnotics in the treatment populations of child/adolescent, child bearing (age) women, the elderly


Click here to register


Course Materials and Continuing Education

NMSU will email registrants course materials, and a link to join the live training two business days before the training.

Upon completion of the training, NMSU will email registrants the training evaluation. Upon completion of the training evaluation, the NMSU will email the registrant the CE certificate.


Refund and Cancellation Policy

We understand, sometimes things come up!

IPA will offer a full refund to registrants who cancel their registration 7 days prior to an event/course. If a registrant would like to cancel their registration within 7 days of the event, no refund will be offered.


Contact: Suzanne Hull, [email protected]